Skip to main content

Table 1 Patients’ characteristics

From: Intravesical prostatic protrusion may affect early postoperative continence undergoing robot-assisted radical prostatectomy

 

Overall population

Group 1

Group 2

p value

Number of patients

119

71

48

 

Median age, years (IQR)

66 (48–76)

64 (48–76)

69 (53–76)

< 0.05

Median BMI, kg/m2 (IQR)

23.5 (18.0–30.6)

23.6 (18.1–28.9)

22.9 (18.0–30.6)

0.8

Median PSA, ng/mL (IQR)

7.8 (3.2–37.1)

7.8 (3.2–34.6)

7.7 (4.3–37.1)

0.45

Clinical stage

    

< T2c

108

64

44

0.96

T3a

10

6

4

 

T3b

1

1

0

 

T4

0

0

0

 

GS of biopsy

    

< 6

21

13

8

0.46

7

50

25

25

 

> 8

48

33

15

 

Risk class (NCCN)

    

Low

14

9

5

0.54

Intermediate

53

27

26

 

High

52

35

17

 

Lymph node dissection (%)

105 (88.2)

62 (87.3)

43 (89.6)

0.75

Nerve sparing (%)

51 (42.8)

28 (39.4)

23 (47.9)

0.15

Median PV, mL (IQR)

26.0 (9.6–66.1)

24.8 (11.1–53.2)

32.8 (9.6–66.1)

< 0.01

Median MUL, mm (IQR)

12.1 (8.9–16.1)

12.1 (9.1–15.3)

12.9 (8.9–16.1)

0.53

Median MUW, mm (IQR)

10.6 (9.8–13.5)

10.8 (9.9–13.4)

10.3 (9.8–13.5)

0.76

Median LT, mm (IQR)

11.1 (7.9–15.1)

11.0 (8.3–15.1)

11.3 (7.9–15.1)

0.66

Median IPP, mm (IQR)

3.8 (0.0–16.5)

1.0 (0.0–4.9)

7.8 (6.2–16.5)

< 0.01

Median IPSS Total score (IQR)

6 (0–28)

6 (0–22)

8 (0–28)

< 0.05

Median IPSS voiding symptom score (IQR)

4 (0–18)

3 (0–15)

5 (0–18)

< 0.01

Median IPSS storage symptom score (IQR)

4 (0–12)

3 (0–12)

4 (0–12)

0.55

Median OABSS score (IQR)

3 (0–10)

2 (0–10)

4 (2–10)

0.45

Median QOL index (IQR)

3 (0–6)

3 (0–6)

3 (0–6)

0.35

Median compliance, mL/cmH2O (IQR)

49.8 (5.0–290.2)

55.9 (5.0–290.2)

42.4 (5.4–153.9)

< 0.01

Median FDV, mL (IQR)

144 (47–400)

144 (81–400)

134 (47–301)

0.62

Median MCC, mL (IQR)

277 (55–470)

282 (120–470)

264 (55–431)

0.96

Median PdetQmax, cmH2O (IQR)

45 (6–90)

41 (6–89)

48 (28–90)

< 0.01

DO (%)

10 (8.4)

7 (9.8)

3 (6.2)

0.22